Xenetic Biosciences Stock Gross Profit
XBIOWDelisted Stock | USD 17.54 0.00 0.00% |
Xenetic Biosciences fundamentals help investors to digest information that contributes to Xenetic Biosciences' financial success or failures. It also enables traders to predict the movement of Xenetic Stock. The fundamental analysis module provides a way to measure Xenetic Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Xenetic Biosciences stock.
Xenetic |
Xenetic Biosciences Company Gross Profit Analysis
Xenetic Biosciences' Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
CompetitionAccording to the company disclosure, Xenetic Biosciences reported 0.0 of gross profit. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Center Now
Portfolio CenterAll portfolio management and optimization tools to improve performance of your portfolios |
All Next | Launch Module |
Xenetic Fundamentals
Return On Equity | -0.42 | |||
Return On Asset | -0.26 | |||
Profit Margin | (1.83) % | |||
Operating Margin | (2.48) % | |||
Revenue | 2.54 M | |||
EBITDA | (4.52 M) | |||
Net Income | (4.13 M) | |||
Cash And Equivalents | 2.02 M | |||
Cash Per Share | 2.32 X | |||
Total Debt | 809.59 K | |||
Debt To Equity | 0.30 % | |||
Current Ratio | 1.60 X | |||
Book Value Per Share | 5.63 X | |||
Cash Flow From Operations | (4.11 M) | |||
Beta | 2.3 | |||
Total Asset | 10.61 M | |||
Retained Earnings | (193.23 M) | |||
Working Capital | 8.78 M | |||
Net Asset | 10.61 M |
About Xenetic Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Xenetic Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Xenetic Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Xenetic Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in Xenetic Stock
If you are still planning to invest in Xenetic Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Xenetic Biosciences' history and understand the potential risks before investing.
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |